Targeted Sequencing And Resequencing Market Size, Share, Trends, Growth Outlook

Targeted Sequencing And Resequencing Market is estimated to increase at a growth rate of 17.4% CAGR over the forecast period from 2024 to 2030.

The global Targeted Sequencing And Resequencing Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technology (Sequencing, Re-sequencing), By Type (DNA, RNA), By Application (Clinical Application, Plant & animal sciences, Drug development, Others), By End-user (Hospitals & clinics, Academic Research, Others).

An introduction to Targeted Sequencing And Resequencing Market in 2024

In 2024, the targeted sequencing and resequencing market is thriving, supported by advancements in DNA sequencing technologies, bioinformatics tools, and the growing demand for high-throughput, targeted genomic analysis solutions in research, clinical diagnostics, and agrigenomics applications. Targeted sequencing and resequencing encompass a variety of techniques such as hybrid capture sequencing, amplicon sequencing, and exome sequencing used to selectively enrich and sequence specific genomic regions, gene panels, or target loci of interest, enabling researchers, geneticists, and breeders to analyze genetic variations, discover novel mutations, and elucidate genotype-phenotype relationships across diverse species and populations. With innovations in probe design, sequencing chemistries, and data analysis algorithms, the market is experiencing rapid expansion and adoption of targeted sequencing and resequencing technologies, offering academic institutions, clinical laboratories, and biotechnology companies scalable and efficient solutions for genetic association studies, population genetics, and molecular breeding applications, driving advancements in genomic research and precision genomics.

Targeted Sequencing And Resequencing Market Trend: Rapid Advancements in Next-Generation Sequencing (NGS) Technology:

A significant trend in the Targeted Sequencing and Resequencing Market is the rapid advancements in next-generation sequencing (NGS) technology. With continuous improvements in sequencing platforms, bioinformatics algorithms, and sample preparation methods, there's a growing adoption of targeted sequencing and resequencing approaches for precise genomic analysis. This trend is driven by the need for high-throughput, cost-effective solutions that enable targeted interrogation of specific genomic regions or variants of interest. Researchers and clinicians are increasingly leveraging NGS technology for applications such as cancer genomics, population studies, and rare disease diagnostics, fueling market growth as the demand for targeted sequencing solutions continues to expand across various research and clinical settings.

Targeted Sequencing And Resequencing Market Driver: Growing Demand for Personalized Medicine and Genomic Biomarker Discovery:

The growing demand for personalized medicine and genomic biomarker discovery serves as a major driver for the Targeted Sequencing and Resequencing Market. As the understanding of genetic factors underlying diseases increases and the adoption of precision medicine approaches accelerates, there's an increasing emphasis on identifying genetic variations associated with disease susceptibility, drug response, and treatment outcomes. Targeted sequencing and resequencing enable comprehensive profiling of specific genomic regions, variants, or genes of interest, facilitating the discovery of actionable biomarkers for patient stratification, therapeutic decision-making, and drug development. This trend is fueling market growth as pharmaceutical companies, academic institutions, and healthcare providers invest in genomic studies and translational research to advance personalized medicine initiatives and improve patient care across a wide range of medical specialties.

Targeted Sequencing And Resequencing Market Opportunity: Expansion into Clinical Diagnostics and Companion Diagnostics:

An opportunity exists for market expansion through the expansion into clinical diagnostics and companion diagnostics. With the increasing adoption of targeted sequencing technology in research settings and the growing demand for molecular diagnostics in clinical practice, there's potential to transition targeted sequencing and resequencing assays into the realm of clinical diagnostics and companion diagnostics. Manufacturers can develop targeted sequencing panels and assays designed for specific disease indications, offering validated solutions for genomic profiling, disease diagnosis, and therapeutic decision support in clinical laboratories. By entering the clinical diagnostics market and providing companion diagnostic tests that guide treatment selection and monitor treatment response, companies can tap into new revenue streams, address unmet clinical needs, and contribute to the advancement of personalized healthcare, thus unlocking new growth opportunities in the Targeted Sequencing and Resequencing Market. This strategic opportunity aligns with the broader trend towards precision medicine adoption and the integration of genomic testing into routine clinical practice, addressing the evolving needs of healthcare providers for accurate and actionable genomic information that informs patient care decisions and improves clinical outcomes.

Targeted Sequencing And Resequencing Market Market Segmentation

By Technology
Sequencing
Re-sequencing
-Electrophoresis-based resequencing
-NGS
-Array-based resequencing
By Type
DNA
RNA
By Application
Clinical Application
Plant & animal sciences
Drug development
Others
By End-User
Hospitals & clinics
Academic Research
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Targeted Sequencing And Resequencing Market Companies

Agilent Technologies
BGI
Bio-Rad Laboratories Inc
DNASTAR Inc
F. Hoffmann-La Roche Ltd
GATC Biotech Ag
Genomatix GmbH
Illumina Inc
Integrated DNA Technologies Inc
Macrogen Inc
Oxford Nanopore Technologies
PacBio
Perkin Elmer Inc
PierianDx
QIAGEN
RainDance Technologies Inc
Thermo Fisher Scientific Inc

Reasons to Buy the Targeted Sequencing And Resequencing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Targeted Sequencing And Resequencing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Targeted Sequencing And Resequencing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Targeted Sequencing And Resequencing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Targeted Sequencing And Resequencing Market Size Outlook, $ Million, 2021 to 2030
3.2 Targeted Sequencing And Resequencing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Targeted Sequencing And Resequencing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Targeted Sequencing And Resequencing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Targeted Sequencing And Resequencing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Targeted Sequencing And Resequencing Industry
4.2 Key Market Trends in Targeted Sequencing And Resequencing Industry
4.3 Potential Opportunities in Targeted Sequencing And Resequencing Industry
4.4 Key Challenges in Targeted Sequencing And Resequencing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Targeted Sequencing And Resequencing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Targeted Sequencing And Resequencing Market Outlook by Segments
7.1 Targeted Sequencing And Resequencing Market Outlook by Segments, $ Million, 2021- 2030
By Technology
Sequencing
Re-sequencing
-Electrophoresis-based resequencing
-NGS
-Array-based resequencing
By Type
DNA
RNA
By Application
Clinical Application
Plant & animal sciences
Drug development
Others
By End-User
Hospitals & clinics
Academic Research
Others

8 North America Targeted Sequencing And Resequencing Market Analysis and Outlook To 2030
8.1 Introduction to North America Targeted Sequencing And Resequencing Markets in 2024
8.2 North America Targeted Sequencing And Resequencing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Targeted Sequencing And Resequencing Market size Outlook by Segments, 2021-2030
By Technology
Sequencing
Re-sequencing
-Electrophoresis-based resequencing
-NGS
-Array-based resequencing
By Type
DNA
RNA
By Application
Clinical Application
Plant & animal sciences
Drug development
Others
By End-User
Hospitals & clinics
Academic Research
Others

9 Europe Targeted Sequencing And Resequencing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Targeted Sequencing And Resequencing Markets in 2024
9.2 Europe Targeted Sequencing And Resequencing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Targeted Sequencing And Resequencing Market Size Outlook by Segments, 2021-2030
By Technology
Sequencing
Re-sequencing
-Electrophoresis-based resequencing
-NGS
-Array-based resequencing
By Type
DNA
RNA
By Application
Clinical Application
Plant & animal sciences
Drug development
Others
By End-User
Hospitals & clinics
Academic Research
Others

10 Asia Pacific Targeted Sequencing And Resequencing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Targeted Sequencing And Resequencing Markets in 2024
10.2 Asia Pacific Targeted Sequencing And Resequencing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Targeted Sequencing And Resequencing Market size Outlook by Segments, 2021-2030
By Technology
Sequencing
Re-sequencing
-Electrophoresis-based resequencing
-NGS
-Array-based resequencing
By Type
DNA
RNA
By Application
Clinical Application
Plant & animal sciences
Drug development
Others
By End-User
Hospitals & clinics
Academic Research
Others

11 South America Targeted Sequencing And Resequencing Market Analysis and Outlook To 2030
11.1 Introduction to South America Targeted Sequencing And Resequencing Markets in 2024
11.2 South America Targeted Sequencing And Resequencing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Targeted Sequencing And Resequencing Market size Outlook by Segments, 2021-2030
By Technology
Sequencing
Re-sequencing
-Electrophoresis-based resequencing
-NGS
-Array-based resequencing
By Type
DNA
RNA
By Application
Clinical Application
Plant & animal sciences
Drug development
Others
By End-User
Hospitals & clinics
Academic Research
Others

12 Middle East and Africa Targeted Sequencing And Resequencing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Targeted Sequencing And Resequencing Markets in 2024
12.2 Middle East and Africa Targeted Sequencing And Resequencing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Targeted Sequencing And Resequencing Market size Outlook by Segments, 2021-2030
By Technology
Sequencing
Re-sequencing
-Electrophoresis-based resequencing
-NGS
-Array-based resequencing
By Type
DNA
RNA
By Application
Clinical Application
Plant & animal sciences
Drug development
Others
By End-User
Hospitals & clinics
Academic Research
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies
BGI
Bio-Rad Laboratories Inc
DNASTAR Inc
F. Hoffmann-La Roche Ltd
GATC Biotech Ag
Genomatix GmbH
Illumina Inc
Integrated DNA Technologies Inc
Macrogen Inc
Oxford Nanopore Technologies
PacBio
Perkin Elmer Inc
PierianDx
QIAGEN
RainDance Technologies Inc
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Technology
Sequencing
Re-sequencing
-Electrophoresis-based resequencing
-NGS
-Array-based resequencing
By Type
DNA
RNA
By Application
Clinical Application
Plant & animal sciences
Drug development
Others
By End-User
Hospitals & clinics
Academic Research
Others